Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.
about
Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamideTamoxifen Resistance: Emerging Molecular TargetsTargeting the androgen receptor in prostate and breast cancer: several new agents in developmentMolecular phenotypes in triple negative breast cancer from African American patients suggest targets for therapyDeciphering the divergent roles of progestogens in breast cancer.Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programsImportance of Breast Cancer Subtype in the Development of Androgen Receptor Directed Therapy.Phosphorylation of androgen receptors at serine 515 is a potential prognostic marker for triple negative breast cancerAndrogen receptor genotypes predict response to endocrine treatment in breast cancer patients.Abiraterone acetate, exemestane or the combination in postmenopausal patients with estrogen receptor-positive metastatic breast cancerAR collaborates with ERα in aromatase inhibitor-resistant breast cancer.Dicer-mediated upregulation of BCRP confers tamoxifen resistance in human breast cancer cells.Prosaposin activates the androgen receptor and potentiates resistance to endocrine treatment in breast cancer.Contribution of Estrone Sulfate to Cell Proliferation in Aromatase Inhibitor (AI) -Resistant, Hormone Receptor-Positive Breast Cancer.Minireview: The androgen receptor in breast tissues: growth inhibitor, tumor suppressor, oncogene?In vitro mechanism for downregulation of ER-α expression by epigallocatechin gallate in ER+/PR+ human breast cancer cellsThe Role of Androgen Receptor in Breast Cancer.The growth response to androgen receptor signaling in ERα-negative human breast cells is dependent on p21 and mediated by MAPK activationAndrogen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancerAndrogen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancerBRCA1 inhibits AR-mediated proliferation of breast cancer cells through the activation of SIRT1Mechanisms of endocrine resistance in breast cancer.Expression of Androgen Receptor in Estrogen Receptor-positive Breast Cancer.Patient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures.Androgens Regulate T47D Cells Motility and Invasion through Actin Cytoskeleton Remodeling.Expression of androgen receptor and its phosphorylated forms in breast cancer progression.The rs4646 and rs12592697 Polymorphisms in CYP19A1 Are Associated with Disease Progression among Patients with Breast Cancer from Different Racial/Ethnic Backgrounds.Differential impact of the expression of the androgen receptor by age in estrogen receptor-positive breast cancer.Critical research gaps and translational priorities for the successful prevention and treatment of breast cancer.Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysisβ-D-glucan inhibits endocrine-resistant breast cancer cell proliferation and alters gene expressionAR Signaling in Breast Cancer.Postmenopausal breast cancer, androgens, and aromatase inhibitors.Androgen receptor expression and outcomes in early breast cancer: a systematic review and meta-analysis.Emerging strategies to overcome resistance to endocrine therapy for breast cancer.Molecular markers for breast cancer diagnosis, prognosis and targeted therapy.Targeting the androgen receptor in breast cancer.Clinical importance of androgen receptor in breast cancer patients treated with adjuvant tamoxifen monotherapy.Cooperative Dynamics of AR and ER Activity in Breast Cancer.Testosterone membrane-initiated action in breast cancer cells: Interaction with the androgen signaling pathway and EPOR.
P2860
Q21195191-7D7B70CE-26AB-4795-912A-3F7B3441D7F3Q26739969-075DE79A-41BC-4AB9-B94B-3EC4D88EFB87Q27009424-E2339266-A369-4200-8B5F-11A56C9A3AC3Q28535227-7C9AD529-ECEC-4905-BCA4-B806F804BD80Q30240711-02083F1A-128D-4F52-A35D-6B3024EE9FA5Q33568421-87D822AB-BE8F-4883-883E-028F6C8778F7Q33632582-1BA54256-C46E-48F2-ADF2-A108EBA82250Q33913872-EBB69FF3-C6D5-4047-BF87-F43758A09A2DQ34228066-8B12E2AD-E5C2-4FB0-9593-566DD86F00C3Q34499512-97FA94CC-B943-4C05-8044-544F283BB948Q35112392-3E24A3DA-AE45-4F4E-ACA7-61E33F69A0C1Q35762594-F427A02B-A278-45F4-BB53-8D73E3DD70B1Q36030567-DC382EAC-AFAC-468B-BBA2-360691315078Q36030787-AF6F7368-2F93-445D-925B-B7119A6EBC69Q36113793-B2FC286D-7E29-4AD7-879F-60880EEEC5CCQ36274172-D2FA459E-4284-4C6C-BA92-810460B8BBB2Q36275556-9C403189-B1DF-4C08-999C-3715AB27CEF4Q36393201-F330BB9F-C36F-4E1E-88C0-18B47643AFB5Q36547919-E12AE4FB-BAA4-43F8-ADC0-23BD50623DA8Q36568006-52232DA2-14FF-43B8-A6CF-16FFBA70A63EQ36605853-DC26B395-7187-4B1D-A96D-D0118A5B6A82Q36851417-CBCA41C8-D0DF-4CB9-A2D0-7B70657DAE51Q37229990-697B774A-01A5-471B-8383-F4CEA9EBFE41Q37281532-844DA39A-3E9B-4D45-B83A-409BFB32D309Q37298916-E1FD4F25-7990-4BCF-BF70-EEA3F18AEB6CQ37418745-27CCDD79-AC94-4FE8-AEE1-262C01AC689AQ37463634-DF56773D-5B21-4C0F-948A-91237C6BA162Q37481133-770E4E8C-A5DA-4E14-AC51-7A21FCF7E57AQ37533025-B15D77A3-CA95-4BB1-A107-645D9867133DQ37564779-64BC154D-8EF3-43C5-A0C3-15A687F0E91FQ37688662-DF8C1EA9-BD2C-4E63-8FD8-BB836C762DC6Q37721492-D3F60CBF-4CA5-478B-ACF3-4624F6329B63Q38097730-88DE28E9-3DF6-45D6-B203-35EFE3478D23Q38165914-7869E461-CF9F-4BB3-8DE8-E67F9D6B01B4Q38221463-F48ECC61-7BD5-4917-9D72-F1A6DC7C7D79Q38236904-E6A1B26C-0C2B-4E17-8974-D94C2DB9B5FAQ38349376-ED1B123F-31E3-4AB3-A88F-D20FD479501AQ38405459-89454E9E-8FAD-4633-BC70-EE3E3544C2CBQ38749913-7198E6D8-258D-4DA2-A195-7F0B048C2719Q39734169-0F7FE35E-5AC6-4022-B00D-657DC6C33ADA
P2860
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Androgen receptor overexpressi ...... in human breast cancer cells.
@ast
Androgen receptor overexpressi ...... in human breast cancer cells.
@en
Androgen receptor overexpressi ...... in human breast cancer cells.
@nl
type
label
Androgen receptor overexpressi ...... in human breast cancer cells.
@ast
Androgen receptor overexpressi ...... in human breast cancer cells.
@en
Androgen receptor overexpressi ...... in human breast cancer cells.
@nl
prefLabel
Androgen receptor overexpressi ...... in human breast cancer cells.
@ast
Androgen receptor overexpressi ...... in human breast cancer cells.
@en
Androgen receptor overexpressi ...... in human breast cancer cells.
@nl
P2093
P2860
P1476
Androgen receptor overexpressi ...... in human breast cancer cells.
@en
P2093
Amanda Beyer
Francesca De Amicis
Gary C Chamness
Irma Parra
Janagi Thirugnansampanthan
Jennifer Selever
Matthew H Herynk
Michael T Lewis
Nancy L Weigel
Sebastiano Andò
P2860
P2888
P356
10.1007/S10549-009-0436-8
P407
P577
2009-06-17T00:00:00Z
P5875
P6179
1045273349